Showing results (131-140 of 181) with videos related to

Sort By:
Pageof 19
Clinical Genitourinary Cancer|November 5, 2018
Radical Prostatectomy With and Without Neoadjuvant Chemohormonal Pretreatment for High-Risk Localized Prostate Cancer: A Comparative Propensity Score Matched AnalysisShintaro Narita, Taketoshi Nara, Sohei Kanda, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 21, 2026
Deferred Cytoreductive Nephrectomy in Unresectable/Metastatic Renal Cell Carcinoma: A Real-World Multicenter Retrospective StudyRyuma Tanaka, Masanao Shinohara, Yohei Kawashima, et al.
BJUI Compass|April 27, 2022
Prognostic impact of proton pump inhibitors for immunotherapy in advanced urothelial carcinomaYoshiharu Okuyama, Shingo Hatakeyama, Kazuyuki Numakura, et al.
Cancer Medicine|September 12, 2025
Effects of Avelumab Maintenance on Advanced Urothelial Carcinoma: A Real-World Multicenter StudyNoritaka Ishii, Yuya Sekine, Masanao Shinohara, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 7, 2020
Efficacy and safety of first-line nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma: A multicenter retrospective studyToshikazu Tanaka, Shingo Hatakeyama, Kazuyuki Numakura, et al.
International Journal of Clinical Oncology|October 17, 2020
Comparison of nivolumab plus ipilimumab with tyrosine kinase inhibitors as first-line therapies for metastatic renal-cell carcinoma: a multicenter retrospective studyKoichi Kido, Shingo Hatakeyama, Kazuyuki Numakura, et al.
Case Reports in Oncology|October 30, 2023
<i>BRCA2</i> Frameshift Mutation in de novo Small-Cell Neuroendocrine Carcinoma of the Prostate: A Case ReportKeisuke Okubo, Shintaro Narita, Atsushi Koizumi, et al.
Hinyokika Kiyo. Acta Urologica Japonica|November 8, 2019
[METASTATIC Mucinous Tubular and Spindle Cell Carcinoma Treated with Nivolumab Successfully : A Case Report]Yoshiko Takahashi, Kazuyuki Numakura, Yu Aoyama, et al.
Urologic Oncology|May 14, 2026
Presenting postoperative mortality as percentages and natural frequencies (1-in-N) in major urologic cancer surgeriesIzuki Ogawa, Masanao Shinohara, Naoki Fujita, et al.
International Journal of Clinical Oncology|May 26, 2024
The lymphocyte-to-monocyte ratio as a significant inflammatory marker associated with survival of patients with metastatic renal cell carcinoma treated using nivolumab plus ipilimumab therapyKazuyuki Numakura, Yuya Sekine, Takahiro Osawa, et al.
Pageof 19